Here we have undertaken a comprehensive evaluation of ganetespib activity in breast cancer cell lines that encompass both luminal and basal histologies, including hormone receptor-positive, HER2-positive and TNBC subtypes, as well as inflammatory breast cancer (IBC). This evidence concerns the gene NR4A1 and breast carcinoma.